ATE539074T1 - Die hiv-protease hemmende verbindungen - Google Patents

Die hiv-protease hemmende verbindungen

Info

Publication number
ATE539074T1
ATE539074T1 AT04810778T AT04810778T ATE539074T1 AT E539074 T1 ATE539074 T1 AT E539074T1 AT 04810778 T AT04810778 T AT 04810778T AT 04810778 T AT04810778 T AT 04810778T AT E539074 T1 ATE539074 T1 AT E539074T1
Authority
AT
Austria
Prior art keywords
hiv protease
inhibiting compounds
protease inhibiting
disclosed
hiv
Prior art date
Application number
AT04810778T
Other languages
English (en)
Inventor
John Randolph
Hui-Ju Chen
David DEGOEY
Charles Flentge
William FLOSI
David GRAMPOVNIK
Peggy Huang
Douglas HUTCHINSON
Dale Kempf
Larry Klein
Ming YEUNG
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Priority claimed from PCT/US2004/037711 external-priority patent/WO2005061487A1/en
Application granted granted Critical
Publication of ATE539074T1 publication Critical patent/ATE539074T1/de

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT04810778T 2003-12-11 2004-11-10 Die hiv-protease hemmende verbindungen ATE539074T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73322703A 2003-12-11 2003-12-11
PCT/US2004/037711 WO2005061487A1 (en) 2003-12-11 2004-11-10 Hiv protease inhibiting compounds

Publications (1)

Publication Number Publication Date
ATE539074T1 true ATE539074T1 (de) 2012-01-15

Family

ID=38249287

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04810778T ATE539074T1 (de) 2003-12-11 2004-11-10 Die hiv-protease hemmende verbindungen

Country Status (4)

Country Link
JP (1) JP5005351B2 (de)
AT (1) ATE539074T1 (de)
ES (1) ES2378669T3 (de)
TW (1) TWI344842B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3378477A1 (de) 2017-03-21 2018-09-26 BIOPROJET Pharma Neue therapeutische verwendungen von h3-liganden

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340588C (en) * 1988-06-13 1999-06-08 Balraj Krishan Handa Amino acid derivatives
JPH07504654A (ja) * 1992-03-11 1995-05-25 ナルヘックス　リミテッド オキソ及びヒドロキシ置換炭化水素のアミン誘導体
DE59303870D1 (de) * 1992-12-23 1996-10-24 Ciba Geigy Ag Antiretrovirale hydrazinderivate
EP0876336B1 (de) * 1995-11-21 2002-06-05 Novartis AG Azahexan-derivate als substratisostere von retroviralen aspartat-proteasen
US5914332A (en) * 1995-12-13 1999-06-22 Abbott Laboratories Retroviral protease inhibiting compounds
PT915841E (pt) * 1996-07-17 2002-08-30 Novartis Ag Derivados anilinopeptidos
AU2001286889A1 (en) * 2000-08-31 2002-03-13 Abbott Laboratories Process and intermediates for preparing retroviral protease inhibitors
WO2002094768A2 (en) * 2001-05-22 2002-11-28 Elan Pharmaceuticals, Inc. Aza hydroxylated ethyl amine compounds

Also Published As

Publication number Publication date
JP2007516255A (ja) 2007-06-21
TW200529804A (en) 2005-09-16
TWI344842B (en) 2011-07-11
JP5005351B2 (ja) 2012-08-22
ES2378669T3 (es) 2012-04-16
HK1094579A1 (en) 2007-04-04

Similar Documents

Publication Publication Date Title
ATE338461T1 (de) Pyrazolpyrimidinfungizide
SE0100903D0 (sv) Compounds
ATE452889T1 (de) Die hiv-protease inhibierende sulfonamide
NO20033848D0 (no) Nitrogenholdige heteroarylforbindelser med en HIV integrase inhiberende aktivitet
ATE506354T1 (de) Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren
DE60041584D1 (de) Substituierte oxoazaheterozyclische verbindungen
DE602004008098D1 (de) Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren
MXPA05012837A (es) Inhibidores de caspasa y usos de los mismos.
ATE403429T1 (de) Spiropyrazol-verbindungen
EA200500203A1 (ru) Новый способ синтеза и новая кристаллическая форма агомелатина и фармацевтические композиции, которые её содержат
CY1106132T1 (el) Παραγωγα πιπepιδινης ως αναστολεις καναλιου καλιου
CY1106716T1 (el) 4-υποκαθισταμενα παραγωγα πιπεριδινης
PT1531672E (pt) Composições antimicrobianas
ATE526323T1 (de) Die hiv-protease hemmende verbindungen
SE0103710D0 (sv) Compounds
HRP20080057T3 (en) 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
TW200613289A (en) Prodrugs of hiv protease inhibitors
EA200600607A1 (ru) Производные имидазопиридина в качестве ингибиторов индуцируемой no-синтазы
ATE516031T1 (de) Verbindungen gegen krebs
ATE419242T1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
NO20015892D0 (no) Inhibitorer av metallproteinaser
TW200716571A (en) Heterocyclic reverse transcriptase inhibitors
ATE539074T1 (de) Die hiv-protease hemmende verbindungen
EA200601106A1 (ru) Трициклические имидазопиридины для применения в качестве ингибиторов желудочной секреции
EA200600608A1 (ru) Производные имидазопиридина как ингибиторы индуцируемой no-синтазы